Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for separating and purifying FMD inactivated virus antigen by applying simulated flow bed

A technology for simulating a fluidized bed and viral antigens, which is applied in the preparation methods of peptides, chemical instruments and methods, viral peptides, etc. It can solve the problems of long purification process time, high packing requirements, and low packing capacity, and shorten the separation time. The effect of purification time, high degree of continuity, and improved preparation efficiency

Active Publication Date: 2019-06-04
SHANGHAI SHEN LIAN BIOMEDICAL CORP
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When the above-mentioned chromatographic method is used for purification, there are often problems such as small sample loading, low packing capacity, single-line operation, long purification process time, large sample loss, large amount of waste liquid, and high treatment costs.
[0004] Simulated fluid bed technology is a purification technology developed in the 1960s. It was only applied to the separation of petrochemical products at first. In the 1990s, Seperex of France applied it to the separation and purification of pharmaceuticals and fine chemicals. For the separation and purification of sugars, isomers, chiral compounds, and biological fermentation broths, and for the separation and purification of inactivated virus antigens in suspension culture of foot-and-mouth disease, the simulated fluid bed technology has not been applied to the separation and purification of virus samples. The application of this technology has very high requirements for the fillers in the fluidized bed body, and it is necessary to find fillers that are resistant to wear, high pressure, and acid and alkali treatment. At present, the fillers of ordinary chromatography for the purification of foot-and-mouth disease inactivated virus antigens are based on dextran or The filler of agarose matrix generally has a particle size of 75um and a pressure-bearing capacity of less than 0.3MPa. Long-term acid-base treatment will easily lead to the loss of functional groups and poor purification effect, which limits the application of simulated fluidized bed technology in the inactivation of foot-and-mouth disease. Applications in the field of viral antigen purification

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for separating and purifying FMD inactivated virus antigen by applying simulated flow bed
  • Method for separating and purifying FMD inactivated virus antigen by applying simulated flow bed

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] The present embodiment provides a kind of method of applying simulated fluidized bed to separate and purify FMD inactivated virus antigen, comprising the following steps:

[0046] S1, balance the chromatographic column of the simulated fluidized bed with an equilibrium buffer solution;

[0047] S2. Load the FMD inactivated virus antigen sample to the simulated fluidized bed chromatography column. During the sample loading process, the chromatographic column can be cleaned of antigen sample impurities and sample desorption and elution, and the cleaning regeneration and balance of the chromatographic packing Liquid equilibration, the purified sample is collected during continuous desorption and elution.

[0048] The concrete steps of described S2 are:

[0049] A. Load the FMD inactivated virus antigen sample to the simulated fluidized bed chromatographic column, detect the effluent of each chromatographic column during the sample loading process, and detect that FMD is k...

Embodiment 2

[0062] The present embodiment provides a kind of method of applying simulated fluidized bed to separate and purify FMD inactivated virus antigen, comprising the following steps:

[0063] S1, balance the chromatographic column of the simulated fluidized bed with an equilibrium buffer solution;

[0064] S2. Load the FMD inactivated virus antigen sample to the simulated fluidized bed chromatography column. During the sample loading process, the chromatographic column can be cleaned of antigen sample impurities and sample desorption and elution, and the cleaning regeneration and balance of the chromatographic packing Liquid equilibration, the purified sample is collected during continuous desorption and elution.

[0065] The concrete steps of described S2 are:

[0066] A. Load the FMD inactivated virus antigen sample to the simulated fluidized bed chromatographic column, detect the effluent of each chromatographic column during the sample loading process, and detect that FMD is k...

Embodiment 3

[0079] The present embodiment provides a kind of method of applying simulated fluidized bed to separate and purify FMD inactivated virus antigen, comprising the following steps:

[0080] S1, balance the chromatographic column of the simulated fluidized bed with an equilibrium buffer solution;

[0081] S2. Load the FMD inactivated virus antigen sample to the simulated fluidized bed chromatography column. During the sample loading process, the chromatographic column can be cleaned of antigen sample impurities and sample desorption and elution, and the cleaning regeneration and balance of the chromatographic packing Liquid equilibration, the purified sample is collected during continuous desorption and elution.

[0082] The concrete steps of described S2 are:

[0083] A. Load the FMD inactivated virus antigen sample to the simulated fluidized bed chromatographic column, detect the effluent of each chromatographic column during the sample loading process, and detect that FMD is k...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
lengthaaaaaaaaaa
lengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for separating and purifying an FMD inactivated virus antigen by applying a simulated flow bed, wherein the method comprises the following steps: balancing a chromatographic column of the simulated flow bed with a balanced buffer solution; loading an FMD inactivated virus antigen sample into the chromatographic column of the simulated flow bed, during sample loading, simultaneously carrying out antigen sample impurity cleaning and sample desorption elution as well as chromatographic filler cleaning and regeneration and balanced liquid balancing on the chromatographic column, and continuously desorbing and eluting the collected and purified sample in the process. The simulated flow bed is applied to separation and purification of the FMD inactivated virus antigen for the first time, the continuous saturated sample loading separation operation can be realized and the sample loading amount is greatly improved; moreover, through the continuous separation and purification via multiple monomer columns, the degree of continuity is high, the separation and purification time is greatly shortened, the preparation efficiency is improved and the operation costis reduced. Moreover, the rigid filler is selected specifically, the loading capacity of the filler namely the pressure resistance is greatly improved, the use amount of the chromatographic filler isreduced, and the service life of the chromatographic column in the simulated flow bed is prolonged.

Description

technical field [0001] The invention relates to the technical field of manufacturing veterinary biological products, in particular to a method for separating and purifying FMD inactivated virus antigens using a simulated fluid bed. Background technique [0002] Foot-and-mouth disease virus (FMD) is an economically devastating viral disease transmitted among artiodactyls. In the foot-and-mouth disease virus vaccine samples, it is mainly the intact virus particles that are related to stimulating the body to produce antibodies and sensitizing lymphocytes. Its sedimentation coefficient is 146S, which is considered to have a parallel relationship with the efficiency of the foot-and-mouth disease vaccine. Internationally, the production of foot-and-mouth disease vaccines mainly adopts suspension culture technology, and the culture reaction is between 3000L-8000L. The subsequent purification process mainly uses methods including polyethylene glycol precipitation, ultrafiltration to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/09C07K1/16
Inventor 姬明放马贵军张震杜祥月
Owner SHANGHAI SHEN LIAN BIOMEDICAL CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products